Zaki Anwar
Interventional Pain Medicine · Frankfort, ILNPI 1346432481
Payments from drug & device makers
Across 38 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$115
- Dexcom, Inc.$88
- Abbott$88
- Novo Nordisk$62
- Stimwave Technologies Incorporated$51
- Boston Scientific$45
- plus $378 from 17 others
What the payments were for
- Food & beverage$825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 5 | $115 |
| Dexcom, Inc. | 3 | $88 |
| Abbott | 4 | $88 |
| Novo Nordisk | 3 | $62 |
| Stimwave Technologies Incorporated | 1 | $51 |
| Boston Scientific | 1 | $45 |
| AbbVie | 2 | $43 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
| Recordati_rare_diseases_inc. | 1 | $31 |
| Shire North American Group Inc | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Si-bone, Inc. | 1 | $25 |
| Orthogenrx Inc. | 1 | $24 |
| Vertos Medical, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Antares Pharma, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Shionogi Inc | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
How this compares
$825 in reported general payments places this provider in the 30th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 67 | $8,702 |
| Buprenorphine | 18 | $7,605 |
| Morphine Sulfate | 198 | $4,373 |
| Morphine Sulfate ErMorphine Sulfate | 126 | $3,878 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 182 | $3,265 |
| Cyclobenzaprine Hcl | 84 | $1,609 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 33 | $1,333 |
| Lidocaine | 19 | $1,260 |
| Gabapentin | 95 | $1,135 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 41 | $1,025 |
| Celecoxib | 25 | $457 |
| Tramadol Hcl | 46 | $439 |
| Pregabalin | 32 | $343 |
| Trazodone Hcl | 42 | $222 |
| Oxycodone Hcl | 13 | $206 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Frankfort
- Alexander FeoktistovNorthfield$1.1M
- Timothy LubenowChicago$856K
- Rifat KhanOak Lawn$731K
- Kenneth CandidoChicago$509K
- Sandeep AminChicago$430K
- Asokumar BuvanendranChicago$182K
- Matthew JaycoxChicago$129K
- Hong VoChicago$91K
- Ramsin BenyaminBloomington$35K
- Adam YoungChicago$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.